Abstract
Pancreatitis is a common and severe toxicity that occurs during asparaginase treatment for acute lymphoblastic leukemia, and has received increasing attention during the last decades. However, no consensus regarding follow-up exists. In this commentary, we highlight potential long-term health-related effects following asparaginase-associated pancreatitis, thereby providing clinicians with a framework when following these patients during and after cessation of therapy.
| Originalsprog | Engelsk |
|---|---|
| Artikelnummer | e30528 |
| Tidsskrift | Pediatric Blood & Cancer |
| Vol/bind | 70 |
| Udgave nummer | 9 |
| Antal sider | 7 |
| ISSN | 1545-5009 |
| DOI |
|
| Status | Udgivet - 2023 |